NeuroOne Medical Technologies Corporation (NMTC) Operating Margin
- Operating margin · 12 months: Value -83.43%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -83.43% | Operating income / revenue. Period ending 2026-06-30. $-7.90M ÷ $9.47M × 100 ≈ -83.43% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -7.90M USD | Operating Income (Loss) |
| Revenue | 9.47M USD | |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | 5.40M USD | Research and Development Expense |
| Selling, general and administration | 7.77M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-7.90M | $9.47M | (m) | $5.40M | $7.77M | -83.43% |
| 2026-03-31 | $-7.07M | $9.72M | (m) | $5.16M | $7.21M | -72.69% |
| 2025-12-31 | $-7.64M | $8.72M | (m) | $5.20M | $7.23M | -87.71% |
| 2025-09-30 | $-4.23M | $9.10M | (m) | $4.98M | $7.38M | -46.46% |
| 2025-06-30 | $-5.67M | $6.63M | (m) | $4.98M | $7.45M | -85.56% |
| 2025-03-31 | $-6.58M | $5.76M | (m) | $4.99M | $7.71M | -114.25% |
| 2024-12-31 | $-6.79M | $5.75M | (m) | $4.75M | $7.77M | -118.02% |
| 2024-09-30 | $-11.89M | $3.45M | (m) | $5.07M | $7.90M | -344.26% |
| 2024-06-30 | $-12.24M | $3.92M | (m) | $5.73M | $7.64M | -311.92% |
| 2024-03-31 | $-12.95M | $3.73M | (m) | $6.43M | $7.62M | -347.54% |
| 2023-12-31 | $-13.56M | $2.82M | (m) | $6.86M | $7.44M | -481.67% |
| 2023-09-30 | $-11.96M | $1.95M | (m) | $6.94M | $6.93M | -612.32% |
| 2023-06-30 | $-10.19M | $1.28M | (m) | $6.60M | $7.24M | -796.49% |
| 2023-03-31 | $-9.44M | $681.59K | (m) | $5.93M | $6.90M | -1385.27% |
| 2022-12-31 | $-9.01M | $252.00K | (m) | $5.43M | $6.90M | -3573.73% |
| 2022-09-30 | $-10.03M | $171.17K | (m) | $4.93M | $6.98M | -5860.15% |
| 2022-06-30 | $-11.27M | $150.72K | (m) | $4.50M | (m) | -7480.70% |
| 2022-03-31 | $-11.55M | $158.76K | (m) | $4.18M | (m) | -7273.85% |
| 2021-12-31 | $-10.88M | $140.42K | (m) | $4.05M | (m) | -7751.13% |
| 2021-09-30 | $-10.22M | $178.15K | (m) | $3.93M | (m) | -5735.86% |
| 2021-06-30 | $-7.69M | (m) | (m) | $3.70M | (m) | (m) |
| 2021-03-31 | $-6.25M | (m) | (m) | $3.25M | (m) | (m) |
| 2020-12-31 | $-5.23M | (m) | (m) | $2.51M | (m) | (m) |
| 2020-09-30 | $-4.90M | (m) | (m) | $2.08M | (m) | (m) |
| 2020-06-30 | $-6.14M | (m) | (m) | $1.75M | (m) | (m) |
| 2020-03-31 | $-6.41M | (m) | (m) | $1.73M | (m) | (m) |
| 2019-12-31 | $-6.55M | (m) | (m) | $1.82M | (m) | (m) |
| 2019-09-30 | $-5.81M | (m) | (m) | $1.53M | (m) | (m) |
| 2019-06-30 | $-5.58M | (m) | (m) | $1.45M | (m) | (m) |
| 2019-03-31 | $-4.89M | (m) | (m) | $1.26M | (m) | (m) |
| 2018-12-31 | $-4.47M | (m) | (m) | $924.25K | (m) | (m) |
| 2018-09-30 | $-4.17M | (m) | (m) | $950.01K | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-3.07M | (m) | (m) | $735.33K | (m) | (m) |
| 2017-09-30 | $-1.98M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $-46.49K | $0.00 | (m) | (m) | (m) | (m) |
| 2017-03-31 | $-36.98K | $0.00 | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-32.61K | $0.00 | (m) | (m) | (m) | (m) |
| 2016-09-30 | $-50.96K | $742.00 | (m) | (m) | (m) | -6868.19% |
| 2016-06-30 | $-47.93K | $742.00 | (m) | (m) | (m) | -6459.30% |
| 2016-03-31 | $-51.73K | $731.00 | (m) | (m) | (m) | -7075.92% |
| 2015-12-31 | $-48.84K | $742.00 | (m) | (m) | (m) | -6582.88% |
| 2015-09-30 | $-44.15K | $627.00 | (m) | (m) | (m) | -7041.95% |
| 2015-06-30 | $-44.24K | $718.00 | (m) | (m) | (m) | -6161.70% |
| 2015-03-31 | $-41.77K | $721.00 | (m) | (m) | (m) | -5793.34% |
| 2014-12-31 | $-35.91K | $773.00 | (m) | (m) | (m) | -4646.05% |
| 2014-09-30 | $-28.62K | $747.00 | (m) | (m) | (m) | -3831.33% |
| 2014-06-30 | $-27.23K | $860.00 | (m) | (m) | (m) | -3166.28% |
| 2014-03-31 | $-26.01K | $1.01K | (m) | (m) | (m) | -2579.96% |
| 2013-12-31 | $-25.09K | $1.25K | (m) | (m) | (m) | -2009.05% |
| 2013-09-30 | (m) | $1.47K | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $1.24K | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $1.18K | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $921.00 | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | $858.00 | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | $2.47K | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | $5.40K | $2.14K | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | $1.17K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |